OPB-31121 was shown to inhibit P-Y-STAT3 and P-Y-STAT5 without affecting upstream kinase activity in various myeloid leukemia cell lines expressing BCR-ABL, FLT3-ITD, or JAK2V617F, as well as in BL and MM cell lines [334]. This evidence concerns the gene STAT5A and Miyoshi myopathy.